Porton Biopharma

Activities: Manufacturing Ingredients Pharmaceutical

Trending Articles

  1. Enhancing solubility with novel excipients With the growing prevalence of complex drug molecules, formulation is becoming ever more challenging. Novel excipients can unlock their potential, says Meera Raghuram, Director...
  2. SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research
  3. Poolbeg Pharma trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg will act as the lead business partner, alongside Johnson & Johnson and other partners, on the University of Manchester and The Christie NHS Foundation Trust research...
  4. Buckland Group launches Quvara Medical after acquiring Becton Dickinson’s Swindon site to boost UK-EU medical manufacturing The acquisition establishes Quvara Medical as a new UK- and EU-based CMO offering GMP- and ISO-certified, high-volume manufacturing services to pharma and medtech clients
  5. SeaBeLife partners with Unither Pharmaceuticals for ophthalmic drug production The new partnership aims to produce clinical and commercial batches of ophthalmic formulation of SeaBeLife’s drug candidate SBL03 to treat degenerative disorders of the...

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

Related Content

Manufacturing

Porton Biopharma Limited licenses Erwinase to Clinigen

The new contract with Clinigen will begin on 1 January 2021
Ingredients

Recombinant cultures for superior enzyme output

A non-GMP enzyme manufacturing process at Porton Biopharma has been converted from native production to recombinant using bioinformatics and next-gen sequencing. David Gervais, Head of Product and Fermentation Development, explains the method
Pharmaceutical

Porton Biopharma appoints first apprentice
Manufacturing

Automating the production of life-saving drugs

Bosch Packaging Technology has developed a new integrated filling line for Porton Biopharma
Manufacturing

Porton Biopharma opens new facility

John Glen MP for Salisbury and South Wiltshire officially opened Porton Biopharma Limited’s new fermentation facility, which will be used to manufacture the company’s life-saving leukaemia drug Erwinase
Research & Development

UK biotech to manufacture novel IBD medicines using gut bacteria spores

Chain Biotech, Porton Biopharma and Scitech have obtained grant funding from Innovate UK to investigate the manufacture of a new class of medicines, targeting a range of clinical conditions such as ulcerative colitis and Crohn’s disease through interaction with the human microbiome
Pharmaceutical

PBL opens new pharmaceutical development labs

Porton Biopharma has officially opened its new multi-million pound pharmaceutical laboratories with a ribbon cutting ceremony, led by Baroness Jane Scott, Bybrook OBE, Leader of Wiltshire Council
Subscribe now